Skip to main content

and
  1. Article

    Open Access

    Treatment with Upadacitinib in Active Psoriatic Arthritis: Efficacy and Safety Data of the First 192 Patients from the UPJOINT Study, a Multicentre, Observational Study in Clinical Practice

    Our aim was to investigate the efficacy and safety of upadacitinib (UPA) in patients with either oligo- or polyarticular active psoriatic arthritis (PsA) using routine clinical practice data from an observatio...

    Stephanie G. Werner, Xenofon Baraliakos, Sabine Reckert in Rheumatology and Therapy (2023)

  2. No Access

    Article

    Loss of type I IFN responsiveness impairs natural killer cell antitumor activity in breast cancer

    Competent type I IFN signaling is the lynchpin of most immune surveillance mechanisms and has recently proven critical to the efficacy of several anticancer agents. Expression of the type I IFN receptor, IFNAR...

    Damien J. Zanker, Katie L. Owen, Nikola Baschuk in Cancer Immunology, Immunotherapy (2021)

  3. Article

    Open Access

    Oral administration of bovine milk-derived extracellular vesicles induces senescence in the primary tumor but accelerates cancer metastasis

    The concept that extracellular vesicles (EVs) from the diet can be absorbed by the intestinal tract of the consuming organism, be bioavailable in various organs, and in-turn exert phenotypic changes is highly ...

    Monisha Samuel, Pamali Fonseka, Rahul Sanwlani, Lahiru Gangoda in Nature Communications (2021)

  4. Article

    Open Access

    STAT3 serine phosphorylation is required for TLR4 metabolic reprogramming and IL-1β expression

    Detection of microbial components such as lipopolysaccharide (LPS) by Toll-like receptor 4 (TLR4) on macrophages induces a robust pro-inflammatory response that is dependent on metabolic reprogramming. These i...

    Jesse J. Balic, Hassan Albargy, Kevin Luu, Francis J. Kirby in Nature Communications (2020)

  5. Article

    Erratum: Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells

    Nat. Immunol. 13, 1171–1177 (2012); published online 11 November 2012; corrected after print 19 November 2012 In the version of this article initially published, two designations for major histocompatibility c...

    Daniel M Andrews, Lucy C Sullivan, Nikola Baschuk, Christopher J Chan in Nature Immunology (2013)

  6. No Access

    Article

    Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells

    NK cell licensing is governed by the interaction of Ly49 receptors with peptide-MHC complexes. Smyth and colleagues show that the nonclassical MHC class I molecule H2-M3 can also license NK cell functional dev...

    Daniel M Andrews, Lucy C Sullivan, Nikola Baschuk, Christopher J Chan in Nature Immunology (2012)

  7. No Access

    Article

    Interleukin-4 impairs granzyme-mediated cytotoxicity of Simian virus 40 large tumor antigen-specific CTL in BALB/c mice

    In this report we analyzed the impact of interleukin-4 (IL-4) on tumor-associated simian virus 40 (SV40) large T-antigen (TAg)-specific CD8+ cytotoxic T cells during rejection of syngeneic SV40 transformed mKSA t...

    Nikola Baschuk, Olaf Utermöhlen, Roland Gugel in Cancer Immunology, Immunotherapy (2007)